Search results for "Infectious Diseases"


 
Results 21 - 30 of about 301 for "Infectious Diseases".
Sort by: Relevance | Newest | Oldest

New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised

One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
https://immattersacp.org/weekly/archives/2022/03/08/2.htm
8 Mar 2022

CDC study shows uptick in C. auris infections in recent years

Cases and transmission of Candida auris have continued to rise since the multidrug-resistant fungus was first reported in the U.S. in 2016. Reports of cases to the CDC rose by 44% in 2019 and 95% in 2021.
https://immattersacp.org/weekly/archives/2023/03/21/1.htm
21 Mar 2023

Long-acting treatments may play a role in eradication of HCV

A cross-sectional survey of patients with or at risk for hepatitis C virus (HCV) found a high acceptability of long-acting treatments such as injections or implants, although daily oral medications were preferred by most. The authors noted that long-acting treatments might contribute to global efforts to eliminate HCV infection.
https://immattersacp.org/weekly/archives/2021/11/02/4.htm
2 Nov 2021

ACP, Annals of Internal Medicine host fifth forum on COVID-19

“COVID-19 Forum V: Evaluation and Care of Patients with Persistent Symptoms Following Acute SARS-CoV-2 Infection” was held on June 9.
https://immattersacp.org/weekly/archives/2021/06/15/2.htm
15 Jun 2021

New research on PASC, COVID-19 infection and vaccination during pregnancy

Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
https://immattersacp.org/weekly/archives/2022/02/15/1.htm
15 Feb 2022

Monkeypox: 5 key points

An expert panel convened by ACP and Annals of Internal Medicine provided five key takeaways about diagnosing and managing monkeypox.
https://immattersacp.org/archives/2022/11/monkeypox-5-key-points.htm
1 Nov 2022

Guideline addresses viral testing in patients with community-acquired pneumonia

The new American Thoracic Society guideline opposes routine use of nucleic acid-based testing for noninfluenza viral pathogens in outpatients with community-acquired pneumonia but identifies some uses for the tests in inpatients.
https://immattersacp.org/weekly/archives/2021/05/11/4.htm
11 May 2021

Internal Medicine Meeting 2021: Virtual Experience to feature three plenary speakers, including Dr. Anthony Fauci

Join ACP for internal medicine's most comprehensive educational program in a new, engaging, interactive, and virtual format.
https://immattersacp.org/weekly/archives/2021/02/23/6.htm
23 Feb 2021

Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions

Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021

DEI or DIE?

The College has become a leader in the world of justice, equity, diversity, and inclusion. While it is tempting to feel a sense of accomplishment, there is a gnawing feeling that more needs to be done.
https://immattersacp.org/archives/2021/05/dei-or-die.htm
1 May 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next